Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
PRRX1
|
ENSG00000116132.7 | paired related homeobox 1 |
ALX4
|
ENSG00000052850.5 | ALX homeobox 4 |
PHOX2A
|
ENSG00000165462.5 | paired like homeobox 2A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
PHOX2A | hg19_v2_chr11_-_71955210_71955227 | -0.56 | 7.7e-04 | Click! |
PRRX1 | hg19_v2_chr1_+_170632250_170632277 | 0.21 | 2.5e-01 | Click! |
ALX4 | hg19_v2_chr11_-_44331679_44331716 | -0.10 | 5.9e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_69865866 | 5.23 |
ENST00000354393.2
|
MYPN
|
myopalladin |
chr5_+_36606700 | 5.07 |
ENST00000416645.2
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
chr3_-_195310802 | 4.68 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
chr6_+_53964336 | 4.59 |
ENST00000447836.2
ENST00000511678.1 |
MLIP
|
muscular LMNA-interacting protein |
chr10_+_24544249 | 4.55 |
ENST00000430453.2
|
KIAA1217
|
KIAA1217 |
chr1_+_170632250 | 3.72 |
ENST00000367760.3
|
PRRX1
|
paired related homeobox 1 |
chr6_-_76072719 | 3.44 |
ENST00000370020.1
|
FILIP1
|
filamin A interacting protein 1 |
chr15_+_51669444 | 2.97 |
ENST00000396399.2
|
GLDN
|
gliomedin |
chr8_-_86253888 | 2.95 |
ENST00000522389.1
ENST00000432364.2 ENST00000517618.1 |
CA1
|
carbonic anhydrase I |
chr7_+_80255472 | 2.85 |
ENST00000428497.1
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chrX_-_15332665 | 2.75 |
ENST00000537676.1
ENST00000344384.4 |
ASB11
|
ankyrin repeat and SOCS box containing 11 |
chr1_-_94147385 | 2.66 |
ENST00000260502.6
|
BCAR3
|
breast cancer anti-estrogen resistance 3 |
chr8_-_26724784 | 2.46 |
ENST00000380573.3
|
ADRA1A
|
adrenoceptor alpha 1A |
chr1_-_92371839 | 2.21 |
ENST00000370399.2
|
TGFBR3
|
transforming growth factor, beta receptor III |
chr15_+_51669513 | 2.17 |
ENST00000558426.1
|
GLDN
|
gliomedin |
chr11_-_40315640 | 2.16 |
ENST00000278198.2
|
LRRC4C
|
leucine rich repeat containing 4C |
chr9_+_124329336 | 2.10 |
ENST00000394340.3
ENST00000436835.1 ENST00000259371.2 |
DAB2IP
|
DAB2 interacting protein |
chr2_-_175629164 | 2.05 |
ENST00000409323.1
ENST00000261007.5 ENST00000348749.5 |
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr1_-_232651312 | 2.02 |
ENST00000262861.4
|
SIPA1L2
|
signal-induced proliferation-associated 1 like 2 |
chr2_+_179184955 | 1.99 |
ENST00000315022.2
|
OSBPL6
|
oxysterol binding protein-like 6 |
chr5_+_140743859 | 1.93 |
ENST00000518069.1
|
PCDHGA5
|
protocadherin gamma subfamily A, 5 |
chr9_-_95298254 | 1.92 |
ENST00000444490.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr7_-_111032971 | 1.83 |
ENST00000450877.1
|
IMMP2L
|
IMP2 inner mitochondrial membrane peptidase-like (S. cerevisiae) |
chr18_-_52989217 | 1.81 |
ENST00000570287.2
|
TCF4
|
transcription factor 4 |
chr18_-_52989525 | 1.76 |
ENST00000457482.3
|
TCF4
|
transcription factor 4 |
chr2_+_102413726 | 1.74 |
ENST00000350878.4
|
MAP4K4
|
mitogen-activated protein kinase kinase kinase kinase 4 |
chr2_-_175629135 | 1.67 |
ENST00000409542.1
ENST00000409219.1 |
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr2_+_29001711 | 1.62 |
ENST00000418910.1
|
PPP1CB
|
protein phosphatase 1, catalytic subunit, beta isozyme |
chr18_-_21891460 | 1.61 |
ENST00000357041.4
|
OSBPL1A
|
oxysterol binding protein-like 1A |
chr1_+_50459990 | 1.61 |
ENST00000448346.1
|
AL645730.2
|
AL645730.2 |
chr4_+_160188306 | 1.54 |
ENST00000510510.1
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr9_-_95298927 | 1.51 |
ENST00000395534.2
|
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr17_-_9694614 | 1.49 |
ENST00000330255.5
ENST00000571134.1 |
DHRS7C
|
dehydrogenase/reductase (SDR family) member 7C |
chr6_+_53883708 | 1.48 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
chr20_+_31823792 | 1.46 |
ENST00000375413.4
ENST00000354297.4 ENST00000375422.2 |
BPIFA1
|
BPI fold containing family A, member 1 |
chr4_+_160188889 | 1.44 |
ENST00000264431.4
|
RAPGEF2
|
Rap guanine nucleotide exchange factor (GEF) 2 |
chr12_-_16761117 | 1.43 |
ENST00000538051.1
|
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr14_-_95236551 | 1.42 |
ENST00000238558.3
|
GSC
|
goosecoid homeobox |
chr12_-_21928515 | 1.38 |
ENST00000537950.1
|
KCNJ8
|
potassium inwardly-rectifying channel, subfamily J, member 8 |
chr16_-_21875424 | 1.38 |
ENST00000541674.1
|
NPIPB4
|
nuclear pore complex interacting protein family, member B4 |
chr9_-_71869642 | 1.37 |
ENST00000600472.1
|
AL358113.1
|
Tight junction protein 2 (Zona occludens 2) isoform 1 variant; Uncharacterized protein |
chr4_-_176812842 | 1.36 |
ENST00000507540.1
|
GPM6A
|
glycoprotein M6A |
chr12_-_118796971 | 1.36 |
ENST00000542902.1
|
TAOK3
|
TAO kinase 3 |
chr2_-_69180083 | 1.31 |
ENST00000328895.4
|
GKN2
|
gastrokine 2 |
chr8_-_10512569 | 1.31 |
ENST00000382483.3
|
RP1L1
|
retinitis pigmentosa 1-like 1 |
chr8_+_67039131 | 1.30 |
ENST00000315962.4
ENST00000353317.5 |
TRIM55
|
tripartite motif containing 55 |
chr1_+_186265399 | 1.29 |
ENST00000367486.3
ENST00000367484.3 ENST00000533951.1 ENST00000367482.4 ENST00000367483.4 ENST00000367485.4 ENST00000445192.2 |
PRG4
|
proteoglycan 4 |
chr1_-_234667504 | 1.27 |
ENST00000421207.1
ENST00000435574.1 |
RP5-855F14.1
|
RP5-855F14.1 |
chr3_-_196242233 | 1.27 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
chr18_+_20714525 | 1.23 |
ENST00000400473.2
|
CABLES1
|
Cdk5 and Abl enzyme substrate 1 |
chr10_+_89420706 | 1.22 |
ENST00000427144.2
|
PAPSS2
|
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr14_+_95078714 | 1.22 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr6_+_53883790 | 1.21 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
chr6_-_138833630 | 1.20 |
ENST00000533765.1
|
NHSL1
|
NHS-like 1 |
chr10_-_75226166 | 1.19 |
ENST00000544628.1
|
PPP3CB
|
protein phosphatase 3, catalytic subunit, beta isozyme |
chr3_+_69985734 | 1.19 |
ENST00000314557.6
ENST00000394351.3 |
MITF
|
microphthalmia-associated transcription factor |
chr12_-_11463353 | 1.18 |
ENST00000279575.1
ENST00000535904.1 ENST00000445719.2 |
PRB4
|
proline-rich protein BstNI subfamily 4 |
chr4_-_100356551 | 1.17 |
ENST00000209665.4
|
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr7_+_107224364 | 1.16 |
ENST00000491150.1
|
BCAP29
|
B-cell receptor-associated protein 29 |
chr5_+_142149932 | 1.15 |
ENST00000274498.4
|
ARHGAP26
|
Rho GTPase activating protein 26 |
chr10_-_102989551 | 1.14 |
ENST00000370193.2
|
LBX1
|
ladybird homeobox 1 |
chr12_-_91573249 | 1.12 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
chr3_-_157824292 | 1.10 |
ENST00000483851.2
|
SHOX2
|
short stature homeobox 2 |
chr10_-_29923893 | 1.08 |
ENST00000355867.4
|
SVIL
|
supervillin |
chr3_+_69985792 | 1.04 |
ENST00000531774.1
|
MITF
|
microphthalmia-associated transcription factor |
chr1_+_109756523 | 1.04 |
ENST00000234677.2
ENST00000369923.4 |
SARS
|
seryl-tRNA synthetase |
chr12_-_16761007 | 1.02 |
ENST00000354662.1
ENST00000441439.2 |
LMO3
|
LIM domain only 3 (rhombotin-like 2) |
chr10_+_53806501 | 1.01 |
ENST00000373975.2
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
chr17_+_53342311 | 1.00 |
ENST00000226067.5
|
HLF
|
hepatic leukemia factor |
chr12_+_12878829 | 1.00 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr6_-_134639235 | 1.00 |
ENST00000533224.1
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr12_-_91546926 | 1.00 |
ENST00000550758.1
|
DCN
|
decorin |
chr5_-_115872142 | 0.97 |
ENST00000510263.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr4_-_100356291 | 0.96 |
ENST00000476959.1
ENST00000482593.1 |
ADH7
|
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide |
chr1_-_178838404 | 0.96 |
ENST00000444255.1
|
ANGPTL1
|
angiopoietin-like 1 |
chr2_-_69180012 | 0.95 |
ENST00000481498.1
|
GKN2
|
gastrokine 2 |
chr8_-_57472154 | 0.92 |
ENST00000499425.1
ENST00000523664.1 ENST00000518943.1 ENST00000524338.1 |
LINC00968
|
long intergenic non-protein coding RNA 968 |
chr2_+_54683419 | 0.91 |
ENST00000356805.4
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1 |
chr21_-_35899113 | 0.90 |
ENST00000492600.1
ENST00000481448.1 ENST00000381132.2 |
RCAN1
|
regulator of calcineurin 1 |
chr7_-_27169801 | 0.89 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chr8_-_16035454 | 0.89 |
ENST00000355282.2
|
MSR1
|
macrophage scavenger receptor 1 |
chr19_-_11456905 | 0.86 |
ENST00000588560.1
ENST00000592952.1 |
TMEM205
|
transmembrane protein 205 |
chr4_-_89951028 | 0.86 |
ENST00000506913.1
|
FAM13A
|
family with sequence similarity 13, member A |
chr1_+_183774285 | 0.84 |
ENST00000539189.1
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1 |
chr9_-_95244781 | 0.82 |
ENST00000375544.3
ENST00000375543.1 ENST00000395538.3 ENST00000450139.2 |
ASPN
|
asporin |
chr1_-_165414414 | 0.82 |
ENST00000359842.5
|
RXRG
|
retinoid X receptor, gamma |
chr15_+_44092784 | 0.82 |
ENST00000458412.1
|
HYPK
|
huntingtin interacting protein K |
chr7_-_93520259 | 0.82 |
ENST00000222543.5
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr1_+_154401791 | 0.81 |
ENST00000476006.1
|
IL6R
|
interleukin 6 receptor |
chr1_+_62439037 | 0.81 |
ENST00000545929.1
|
INADL
|
InaD-like (Drosophila) |
chr1_+_12976450 | 0.81 |
ENST00000361079.2
|
PRAMEF7
|
PRAME family member 7 |
chr8_-_62602327 | 0.80 |
ENST00000445642.3
ENST00000517847.2 ENST00000389204.4 ENST00000517661.1 ENST00000517903.1 ENST00000522603.1 ENST00000522349.1 ENST00000522835.1 ENST00000541428.1 ENST00000518306.1 |
ASPH
|
aspartate beta-hydroxylase |
chr5_-_136649218 | 0.80 |
ENST00000510405.1
|
SPOCK1
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 |
chrX_+_39868501 | 0.80 |
ENST00000447651.1
|
AC092198.1
|
AC092198.1 |
chr17_-_5321549 | 0.80 |
ENST00000572809.1
|
NUP88
|
nucleoporin 88kDa |
chr12_-_75784669 | 0.79 |
ENST00000552497.1
ENST00000551829.1 ENST00000436898.1 ENST00000442339.2 |
CAPS2
|
calcyphosine 2 |
chr4_+_76649753 | 0.78 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
chr6_+_55192267 | 0.78 |
ENST00000340465.2
|
GFRAL
|
GDNF family receptor alpha like |
chr7_+_90338547 | 0.78 |
ENST00000446790.1
|
CDK14
|
cyclin-dependent kinase 14 |
chr9_-_95298314 | 0.77 |
ENST00000344604.5
ENST00000375540.1 |
ECM2
|
extracellular matrix protein 2, female organ and adipocyte specific |
chr1_-_242162375 | 0.74 |
ENST00000357246.3
|
MAP1LC3C
|
microtubule-associated protein 1 light chain 3 gamma |
chr19_-_11456872 | 0.73 |
ENST00000586218.1
|
TMEM205
|
transmembrane protein 205 |
chr5_+_137203557 | 0.73 |
ENST00000515645.1
|
MYOT
|
myotilin |
chr5_-_115872124 | 0.73 |
ENST00000515009.1
|
SEMA6A
|
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
chr6_-_137314371 | 0.71 |
ENST00000432330.1
ENST00000418699.1 |
RP11-55K22.5
|
RP11-55K22.5 |
chr2_-_55496174 | 0.71 |
ENST00000417363.1
ENST00000412530.1 ENST00000394600.3 ENST00000366137.2 ENST00000420637.1 |
MTIF2
|
mitochondrial translational initiation factor 2 |
chr14_-_38064198 | 0.71 |
ENST00000250448.2
|
FOXA1
|
forkhead box A1 |
chr10_+_24755416 | 0.71 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
chr16_+_7382745 | 0.70 |
ENST00000436368.2
ENST00000311745.5 ENST00000355637.4 ENST00000340209.4 |
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr13_+_102142296 | 0.69 |
ENST00000376162.3
|
ITGBL1
|
integrin, beta-like 1 (with EGF-like repeat domains) |
chr5_+_142149955 | 0.69 |
ENST00000378004.3
|
ARHGAP26
|
Rho GTPase activating protein 26 |
chr2_+_223725723 | 0.68 |
ENST00000535678.1
|
ACSL3
|
acyl-CoA synthetase long-chain family member 3 |
chr1_+_183774240 | 0.68 |
ENST00000360851.3
|
RGL1
|
ral guanine nucleotide dissociation stimulator-like 1 |
chr21_+_17442799 | 0.68 |
ENST00000602580.1
ENST00000458468.1 ENST00000602935.1 |
LINC00478
|
long intergenic non-protein coding RNA 478 |
chr10_-_90967063 | 0.68 |
ENST00000371852.2
|
CH25H
|
cholesterol 25-hydroxylase |
chr9_+_87286997 | 0.68 |
ENST00000395866.2
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2 |
chr12_-_118796910 | 0.67 |
ENST00000541186.1
ENST00000539872.1 |
TAOK3
|
TAO kinase 3 |
chr7_-_93520191 | 0.67 |
ENST00000545378.1
|
TFPI2
|
tissue factor pathway inhibitor 2 |
chr2_+_101437487 | 0.67 |
ENST00000427413.1
ENST00000542504.1 |
NPAS2
|
neuronal PAS domain protein 2 |
chr14_+_101293687 | 0.66 |
ENST00000455286.1
|
MEG3
|
maternally expressed 3 (non-protein coding) |
chr3_-_194188956 | 0.66 |
ENST00000256031.4
ENST00000446356.1 |
ATP13A3
|
ATPase type 13A3 |
chr21_+_43619796 | 0.66 |
ENST00000398457.2
|
ABCG1
|
ATP-binding cassette, sub-family G (WHITE), member 1 |
chr1_+_243419306 | 0.66 |
ENST00000355875.4
ENST00000391846.1 ENST00000366541.3 ENST00000343783.6 |
SDCCAG8
|
serologically defined colon cancer antigen 8 |
chr10_-_10836865 | 0.66 |
ENST00000446372.2
|
SFTA1P
|
surfactant associated 1, pseudogene |
chr10_-_50396407 | 0.64 |
ENST00000374153.2
ENST00000374151.3 |
C10orf128
|
chromosome 10 open reading frame 128 |
chr6_+_121756809 | 0.63 |
ENST00000282561.3
|
GJA1
|
gap junction protein, alpha 1, 43kDa |
chr6_+_3259148 | 0.63 |
ENST00000419065.2
ENST00000473000.2 ENST00000451246.2 ENST00000454610.2 |
PSMG4
|
proteasome (prosome, macropain) assembly chaperone 4 |
chr19_-_11456935 | 0.63 |
ENST00000590788.1
ENST00000586590.1 ENST00000589555.1 ENST00000586956.1 ENST00000593256.2 ENST00000447337.1 ENST00000591677.1 ENST00000586701.1 ENST00000589655.1 |
TMEM205
RAB3D
|
transmembrane protein 205 RAB3D, member RAS oncogene family |
chr12_-_47219733 | 0.63 |
ENST00000547477.1
ENST00000447411.1 ENST00000266579.4 |
SLC38A4
|
solute carrier family 38, member 4 |
chr4_-_76957214 | 0.63 |
ENST00000306621.3
|
CXCL11
|
chemokine (C-X-C motif) ligand 11 |
chr1_+_198985262 | 0.62 |
ENST00000432488.1
|
RP11-16L9.4
|
RP11-16L9.4 |
chr10_-_50396425 | 0.62 |
ENST00000374148.1
|
C10orf128
|
chromosome 10 open reading frame 128 |
chr1_+_145525015 | 0.61 |
ENST00000539363.1
ENST00000538811.1 |
ITGA10
|
integrin, alpha 10 |
chr8_-_93107443 | 0.61 |
ENST00000360348.2
ENST00000520428.1 ENST00000518992.1 ENST00000520556.1 ENST00000518317.1 ENST00000521319.1 ENST00000521375.1 ENST00000518449.1 |
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr6_-_134639180 | 0.61 |
ENST00000367858.5
|
SGK1
|
serum/glucocorticoid regulated kinase 1 |
chr5_-_142780280 | 0.61 |
ENST00000424646.2
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
chr16_+_24549014 | 0.60 |
ENST00000564314.1
ENST00000567686.1 |
RBBP6
|
retinoblastoma binding protein 6 |
chr5_+_140762268 | 0.59 |
ENST00000518325.1
|
PCDHGA7
|
protocadherin gamma subfamily A, 7 |
chr3_-_12587055 | 0.59 |
ENST00000564146.3
|
C3orf83
|
chromosome 3 open reading frame 83 |
chr16_+_6533729 | 0.59 |
ENST00000551752.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr11_+_12766583 | 0.58 |
ENST00000361985.2
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
chr6_-_107235378 | 0.58 |
ENST00000606430.1
|
RP1-60O19.1
|
RP1-60O19.1 |
chr11_-_58035732 | 0.57 |
ENST00000395079.2
|
OR10W1
|
olfactory receptor, family 10, subfamily W, member 1 |
chr19_+_50016610 | 0.57 |
ENST00000596975.1
|
FCGRT
|
Fc fragment of IgG, receptor, transporter, alpha |
chr4_-_176733897 | 0.57 |
ENST00000393658.2
|
GPM6A
|
glycoprotein M6A |
chr8_+_86851932 | 0.57 |
ENST00000517368.1
|
CTA-392E5.1
|
CTA-392E5.1 |
chr4_-_83769996 | 0.57 |
ENST00000511338.1
|
SEC31A
|
SEC31 homolog A (S. cerevisiae) |
chr3_+_186692745 | 0.57 |
ENST00000438590.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr5_+_137203465 | 0.56 |
ENST00000239926.4
|
MYOT
|
myotilin |
chr2_+_119699742 | 0.55 |
ENST00000327097.4
|
MARCO
|
macrophage receptor with collagenous structure |
chr6_+_3259122 | 0.55 |
ENST00000438998.2
ENST00000380305.4 |
PSMG4
|
proteasome (prosome, macropain) assembly chaperone 4 |
chr13_+_20268547 | 0.55 |
ENST00000601204.1
|
AL354808.2
|
AL354808.2 |
chr1_-_21377383 | 0.54 |
ENST00000374935.3
|
EIF4G3
|
eukaryotic translation initiation factor 4 gamma, 3 |
chr9_+_27524283 | 0.54 |
ENST00000276943.2
|
IFNK
|
interferon, kappa |
chrX_+_11311533 | 0.54 |
ENST00000380714.3
ENST00000380712.3 ENST00000348912.4 |
AMELX
|
amelogenin, X-linked |
chr19_-_11456722 | 0.54 |
ENST00000354882.5
|
TMEM205
|
transmembrane protein 205 |
chr2_+_119699864 | 0.54 |
ENST00000541757.1
ENST00000412481.1 |
MARCO
|
macrophage receptor with collagenous structure |
chr6_-_56492816 | 0.54 |
ENST00000522360.1
|
DST
|
dystonin |
chr3_+_12329397 | 0.54 |
ENST00000397015.2
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr4_+_169575875 | 0.53 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
chr12_-_91573316 | 0.53 |
ENST00000393155.1
|
DCN
|
decorin |
chr2_-_145275828 | 0.53 |
ENST00000392861.2
ENST00000409211.1 |
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr16_+_6533380 | 0.53 |
ENST00000552089.1
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1 |
chr1_-_157069590 | 0.53 |
ENST00000454449.2
|
ETV3L
|
ets variant 3-like |
chr3_-_149293990 | 0.52 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
chr12_-_9360966 | 0.52 |
ENST00000261336.2
|
PZP
|
pregnancy-zone protein |
chr3_-_167191814 | 0.52 |
ENST00000466903.1
ENST00000264677.4 |
SERPINI2
|
serpin peptidase inhibitor, clade I (pancpin), member 2 |
chr12_-_7656357 | 0.52 |
ENST00000396620.3
ENST00000432237.2 ENST00000359156.4 |
CD163
|
CD163 molecule |
chr2_+_223725652 | 0.52 |
ENST00000357430.3
ENST00000392066.3 |
ACSL3
|
acyl-CoA synthetase long-chain family member 3 |
chr3_+_153839149 | 0.51 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
chr12_-_91573132 | 0.51 |
ENST00000550563.1
ENST00000546370.1 |
DCN
|
decorin |
chr10_-_50396357 | 0.51 |
ENST00000453436.1
ENST00000474718.1 |
C10orf128
|
chromosome 10 open reading frame 128 |
chr5_-_16738451 | 0.51 |
ENST00000274203.9
ENST00000515803.1 |
MYO10
|
myosin X |
chr10_+_13141441 | 0.50 |
ENST00000263036.5
|
OPTN
|
optineurin |
chr5_+_98109322 | 0.50 |
ENST00000513185.1
|
RGMB
|
repulsive guidance molecule family member b |
chr1_-_178840157 | 0.50 |
ENST00000367629.1
ENST00000234816.2 |
ANGPTL1
|
angiopoietin-like 1 |
chr8_-_6420930 | 0.50 |
ENST00000325203.5
|
ANGPT2
|
angiopoietin 2 |
chr3_-_124774802 | 0.49 |
ENST00000311127.4
|
HEG1
|
heart development protein with EGF-like domains 1 |
chr5_-_134735568 | 0.49 |
ENST00000510038.1
ENST00000304332.4 |
H2AFY
|
H2A histone family, member Y |
chr2_+_75873902 | 0.49 |
ENST00000393909.2
ENST00000358788.6 ENST00000409374.1 |
MRPL19
|
mitochondrial ribosomal protein L19 |
chr12_-_10959892 | 0.49 |
ENST00000240615.2
|
TAS2R8
|
taste receptor, type 2, member 8 |
chr12_-_118797475 | 0.48 |
ENST00000541786.1
ENST00000419821.2 ENST00000541878.1 |
TAOK3
|
TAO kinase 3 |
chr11_+_1295809 | 0.48 |
ENST00000598274.1
|
AC136297.1
|
Uncharacterized protein |
chr4_+_76649797 | 0.48 |
ENST00000538159.1
ENST00000514213.2 |
USO1
|
USO1 vesicle transport factor |
chr4_-_76649546 | 0.48 |
ENST00000508510.1
ENST00000509561.1 ENST00000499709.2 ENST00000511868.1 |
G3BP2
|
GTPase activating protein (SH3 domain) binding protein 2 |
chr12_+_49621658 | 0.47 |
ENST00000541364.1
|
TUBA1C
|
tubulin, alpha 1c |
chr1_+_87012753 | 0.47 |
ENST00000370563.3
|
CLCA4
|
chloride channel accessory 4 |
chr16_+_22518495 | 0.47 |
ENST00000541154.1
|
NPIPB5
|
nuclear pore complex interacting protein family, member B5 |
chr7_+_55980331 | 0.46 |
ENST00000429591.2
|
ZNF713
|
zinc finger protein 713 |
chr4_-_68829144 | 0.46 |
ENST00000508048.1
|
TMPRSS11A
|
transmembrane protease, serine 11A |
chr11_-_58499434 | 0.46 |
ENST00000344743.3
ENST00000278400.3 |
GLYAT
|
glycine-N-acyltransferase |
chr7_+_123241908 | 0.46 |
ENST00000434204.1
ENST00000437535.1 ENST00000451215.1 |
ASB15
|
ankyrin repeat and SOCS box containing 15 |
chr17_+_75181292 | 0.46 |
ENST00000431431.2
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
chr10_+_13141585 | 0.46 |
ENST00000378764.2
|
OPTN
|
optineurin |
chrX_+_119737806 | 0.45 |
ENST00000371317.5
|
MCTS1
|
malignant T cell amplified sequence 1 |
chr4_-_186578674 | 0.45 |
ENST00000438278.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
chr4_+_155484103 | 0.45 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
chr9_+_88556444 | 0.45 |
ENST00000376040.1
|
NAA35
|
N(alpha)-acetyltransferase 35, NatC auxiliary subunit |
chr12_-_8088871 | 0.44 |
ENST00000075120.7
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3 |
chr20_+_36974759 | 0.44 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.8 | 2.5 | GO:0003099 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.6 | 1.8 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.5 | 2.1 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.5 | 1.4 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.5 | 5.1 | GO:0070779 | gamma-aminobutyric acid biosynthetic process(GO:0009449) D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 2.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 3.0 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.4 | 2.1 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.4 | 3.7 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.4 | 4.9 | GO:0048664 | neuron fate determination(GO:0048664) |
0.4 | 1.2 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
0.4 | 1.5 | GO:0042710 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.3 | 1.0 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.3 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 0.3 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
0.3 | 5.4 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 3.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 2.8 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.2 | 0.7 | GO:0060738 | epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
0.2 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.2 | 5.2 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.2 | 0.6 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 2.4 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.2 | 0.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.2 | 0.7 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
0.2 | 0.5 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.2 | 0.5 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 0.6 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 0.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.5 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 0.4 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.1 | 0.7 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 0.7 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 1.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.1 | 0.5 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.1 | 0.4 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
0.1 | 0.3 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.1 | 0.6 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.5 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.7 | GO:0099540 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.1 | 1.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.4 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 1.4 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.1 | 1.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 1.7 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.5 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.1 | 1.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.1 | 1.3 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 3.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 0.4 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.1 | 1.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.3 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 0.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
0.1 | 0.6 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 1.2 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.8 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.5 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.1 | 0.6 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.4 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
0.1 | 0.3 | GO:0060166 | olfactory pit development(GO:0060166) |
0.1 | 0.2 | GO:2001186 | negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
0.1 | 0.7 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 1.0 | GO:0060087 | relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.1 | 2.4 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 1.2 | GO:0043248 | proteasome assembly(GO:0043248) |
0.1 | 1.4 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.1 | 0.8 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 3.8 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.4 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.1 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 0.2 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.1 | 0.3 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 0.5 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.1 | 0.4 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
0.1 | 3.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.5 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 1.0 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.2 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.0 | 0.1 | GO:1903414 | spleen trabecula formation(GO:0060345) iron cation export(GO:1903414) ferrous iron export(GO:1903988) |
0.0 | 0.4 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.0 | 0.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.0 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.0 | 0.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.0 | 0.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.0 | 0.2 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.0 | 0.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 2.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 1.5 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 1.8 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.7 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.0 | 0.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.0 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.7 | GO:0051775 | response to redox state(GO:0051775) |
0.0 | 0.2 | GO:0010615 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
0.0 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
0.0 | 0.1 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.5 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.5 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.0 | 0.5 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.0 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.0 | 0.3 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.0 | 0.3 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 1.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 1.5 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.4 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 1.3 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.5 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 1.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.8 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.0 | 1.9 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.3 | GO:0015825 | L-serine transport(GO:0015825) |
0.0 | 1.8 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.0 | 0.4 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.1 | GO:0070562 | regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 1.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 4.5 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.5 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.6 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.9 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.2 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.0 | 0.4 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.2 | GO:0030242 | pexophagy(GO:0030242) |
0.0 | 0.4 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
0.0 | 1.1 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 4.1 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 5.2 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.3 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.2 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.2 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.0 | 0.3 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.9 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.6 | GO:0043066 | negative regulation of apoptotic process(GO:0043066) negative regulation of programmed cell death(GO:0043069) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.4 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.0 | 2.8 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.1 | GO:0070836 | caveola assembly(GO:0070836) |
0.0 | 0.1 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.0 | 0.1 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.0 | 0.6 | GO:1901099 | negative regulation of signal transduction in absence of ligand(GO:1901099) negative regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001240) |
0.0 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.2 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.0 | 0.3 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.0 | 0.0 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.0 | 0.5 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.1 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.0 | 0.2 | GO:0046069 | cGMP catabolic process(GO:0046069) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:1990032 | parallel fiber(GO:1990032) |
0.6 | 1.8 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 2.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 3.2 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.2 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 4.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.1 | 3.7 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.4 | GO:0070993 | translation preinitiation complex(GO:0070993) |
0.1 | 0.6 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.1 | 1.2 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 1.6 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.6 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.1 | 0.3 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.1 | 0.4 | GO:0031417 | NatC complex(GO:0031417) |
0.1 | 0.5 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.9 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 0.8 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 1.0 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 2.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 1.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 2.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.3 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.1 | 0.3 | GO:0031905 | early endosome lumen(GO:0031905) |
0.1 | 7.5 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.1 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.1 | 0.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.3 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.0 | 0.3 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.2 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.0 | 0.4 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.0 | 0.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 7.7 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.7 | GO:0098794 | postsynapse(GO:0098794) |
0.0 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.0 | 10.0 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.7 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.0 | 2.7 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.5 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.1 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.0 | 1.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 5.3 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.0 | 0.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.3 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.0 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.3 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.7 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.3 | GO:0043194 | axon initial segment(GO:0043194) |
0.0 | 0.1 | GO:0032280 | symmetric synapse(GO:0032280) |
0.0 | 3.7 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.3 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.3 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.0 | 0.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 0.5 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 1.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 2.1 | GO:0005923 | bicellular tight junction(GO:0005923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 4.2 | GO:0070052 | collagen V binding(GO:0070052) |
0.8 | 2.5 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.7 | 2.2 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.5 | 2.1 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.5 | 5.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.4 | 1.2 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.4 | 3.0 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.0 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.3 | 1.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.3 | 1.6 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.3 | 2.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.3 | 0.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 0.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.3 | 2.8 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.2 | 2.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.2 | 0.7 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 0.8 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 1.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.2 | 5.4 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.2 | 0.5 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.2 | 3.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 1.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 5.8 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 3.7 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.9 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.6 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.6 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.1 | 0.7 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.1 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.1 | 0.5 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 1.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 4.7 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.1 | 0.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.6 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.5 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.1 | 3.6 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 0.6 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) |
0.1 | 2.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.6 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 0.3 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.1 | 0.2 | GO:0052591 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.1 | 2.8 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.5 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.1 | 0.6 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.1 | 0.4 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.1 | 1.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 1.1 | GO:0038187 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.0 | 2.6 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0097689 | iron channel activity(GO:0097689) |
0.0 | 0.3 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.0 | 0.5 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.0 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 1.3 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 1.2 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 1.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.0 | 0.9 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.0 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.0 | 0.8 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.8 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.0 | 0.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 1.4 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.7 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 5.8 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 5.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 2.0 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.0 | 0.2 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.0 | 0.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.0 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.2 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.4 | GO:0036122 | BMP binding(GO:0036122) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.2 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.8 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.3 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.6 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.0 | 0.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 0.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.0 | 0.1 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.1 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.0 | 0.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.0 | 0.5 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 2.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.4 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:1904315 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1904315) |
0.0 | 0.1 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.0 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.0 | 0.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.0 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.0 | 0.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.0 | 0.1 | GO:0043176 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.3 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 0.8 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 2.4 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 4.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 3.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 0.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.0 | 2.1 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.1 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 1.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 1.7 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 1.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 4.1 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 2.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.8 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.6 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 2.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 7.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 1.1 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.5 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.4 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.5 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.7 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.2 | 3.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 2.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 3.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 5.7 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 1.7 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 2.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 3.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 1.9 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 1.2 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.6 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 2.8 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 1.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 1.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 1.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.6 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.3 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.4 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.5 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.8 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.0 | 2.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.5 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.0 | 0.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 1.2 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 1.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.5 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.0 | 0.3 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 2.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.0 | 0.3 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 3.2 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |